NTx-265

· Stem Cell Therapeutics Corp.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NTx-265, covering 2009-08-12 to 2011-11-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients [Phase 2]

See pricing